ProfileGDS5678 / 1458453_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 24% 20% 20% 20% 21% 21% 25% 20% 19% 20% 20% 20% 30% 20% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5894724
GSM967853U87-EV human glioblastoma xenograft - Control 22.4780220
GSM967854U87-EV human glioblastoma xenograft - Control 32.4756620
GSM967855U87-EV human glioblastoma xenograft - Control 42.4219620
GSM967856U87-EV human glioblastoma xenograft - Control 52.4417321
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.567521
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.6232725
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4605820
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4374919
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4715320
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4707820
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4488420
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.6744730
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4769920